Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis

An Evaluation of the Carcinoembryonic Antigen (CEA) Test for Monitoring Patients With Resected Colon Cancer

Charles G. Moertel · JAMA · 1993 · 440 citations

Medicine, Oncology, Surgery +17

Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

Journal of Clinical Oncology · 1996 · 431 citations

Medicine, Oncology, Cancer Control +16

Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer

Jean-Louis Pujol, Jean‐Christophe Grenier, J.-P. Daurès et al. · Lung Cancer · 1993 · 320 citations

Medicine, Cell Biology, Oncology +8

The international system for staging lung cancer

Clifton F. Mountain · Seminars in Surgical Oncology · 2000 · 217 citations

Medicine, Oncology, Surgery +17

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.

Stephen L. Graziano, Rummana Mazid, Nancy Newman et al. · Journal of Clinical Oncology · 1989 · 189 citations

Medicine, Oncology, Chemotherapy +10